-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15Introduction and utilisation of high priced HCV medicines across Europe; implications for the futureby Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan, Patricia Vella Bonanno, Ljiljana Sović Brkičić, Anna Bucsics, Guillame Dedet, Jaran Eriksen, Joseph O Fadare, Jurij Fürst, Gisselle Gallego, Isabella Piassi Godói, Isabella Piassi Godói, Augusto Afonso Guerra Junior, Augusto Afonso Guerra Junior, Hakki Gürsöz, Saira Jan, Saira Jan, Jan Jones, Saim Kerman, Roberta Joppi, Ott Laius, Newman Madzikwa, Einar Magnusson, Mojca Maticic, Vanda Markovic-Pekovic, Vanda Markovic-Pekovic, Amos Massele, Olayinka Ogunleye, Olayinka Ogunleye, Aisling O’Leary, Jutta Piessnegger, Catherine Sermet, Steven Simoens, Celda Tiroyakgosi, Ilse Truter, Magnus Thyberg, Kristina Tomekova, Magdalene Wladysiuk, Sortiris Vandoros, Elif Hilal Vural, Corinne Zara, Brian Godman, Brian GodmanGet full text
Published 2016-07-01
Article